company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20014000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20014000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,714000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,211000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,183000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1595000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17311000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17311000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-644000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-644000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-644000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3000000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,15000000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,38660000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,77000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,50737000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,50737000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,32782000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,254000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24350000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24350000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,829000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,469000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1755000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1527000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22824000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22824000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-249000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5397000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3400000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2246000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2246000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1561000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-999000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5000000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,72000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2512000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2512000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-22558000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,415000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6038000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6038000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,209000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,145000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,757000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-874000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5801000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5801000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2750000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2750000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2750000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-786000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-999000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1785000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1785000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4836000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,415000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6631000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6631000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,209000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,154000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,601000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-111000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5778000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5778000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,650000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,650000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,650000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-775000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-773000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-773000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5901000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-10 16:38:23+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18312000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-10 16:38:23+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18312000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-10 16:38:23+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,620000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-10 16:38:23+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,324000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-10 16:38:23+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,998000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-10 16:38:23+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-653000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-10 16:38:23+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17023000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-10 16:38:23+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17023000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-10 16:38:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-249000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-10 16:38:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5397000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-10 16:38:23+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,650000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-10 16:38:23+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4996000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-10 16:38:23+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4996000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-10 16:38:23+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-775000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-10 16:38:23+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5000000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-10 16:38:23+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,72000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-10 16:38:23+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4297000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-10 16:38:23+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4297000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-10 16:38:23+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-17722000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5588000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5588000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,208000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,97000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,221000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,162000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4900000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4900000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-38000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-38000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-38000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5000000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,57000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5057000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5057000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,119000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-12 16:18:55+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11681000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-12 16:18:55+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11681000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-12 16:18:55+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,411000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-12 16:18:55+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,170000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-12 16:18:55+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,397000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-12 16:18:55+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-542000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-12 16:18:55+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11245000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-12 16:18:55+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11245000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-12 16:18:55+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-249000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-12 16:18:55+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5397000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-12 16:18:55+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5646000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-12 16:18:55+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5646000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-12 16:18:55+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5000000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-12 16:18:55+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,70000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-12 16:18:55+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5070000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-12 16:18:55+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5070000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-12 16:18:55+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11821000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6093000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6093000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,203000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,73000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,176000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-704000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6345000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6345000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-211000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5397000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5608000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5608000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,13000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,13000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,13000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11940000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-47973000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-47973000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,869000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,789000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6535000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2983000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-36797000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-36797000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-664000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-109445000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,38115000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-71994000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-71994000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5237000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,75648000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,77506000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,147917000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,147917000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,39126000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,925000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16493000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16493000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,226000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,72000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2684000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3676000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9835000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9835000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-119000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10037000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14060000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3904000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3904000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-824000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-273000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1097000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1097000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7028000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,925000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-14 15:41:47+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31480000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-14 15:41:47+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31480000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-14 15:41:47+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,643000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-14 15:41:47+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,717000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-14 15:41:47+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3851000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-14 15:41:47+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-693000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-14 15:41:47+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-26962000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-14 15:41:47+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-26962000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-14 15:41:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-545000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-14 15:41:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-99408000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-14 15:41:47+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24055000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-14 15:41:47+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-75898000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-14 15:41:47+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-75898000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-14 15:41:47+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4413000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-14 15:41:47+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,75648000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-14 15:41:47+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,77779000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-14 15:41:47+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,149014000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-14 15:41:47+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,149014000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-14 15:41:47+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,46154000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37518000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37518000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,852000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,862000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4608000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1567000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-32763000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-32763000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-545000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-99408000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,26805000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-73148000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-73148000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5199000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-999000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,75648000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,77779000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,147229000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,147229000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,41318000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,415000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11329000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11329000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,224000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,357000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1050000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,231000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9467000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9467000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-382000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-14481000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22101000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7238000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7238000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-815000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,31000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-784000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-784000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3013000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-10 16:19:23+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20151000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-10 16:19:23+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20151000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-10 16:19:23+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,419000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-10 16:19:23+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,360000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-10 16:19:23+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2801000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-10 16:19:23+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-924000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-10 16:19:23+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17495000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-10 16:19:23+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17495000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-10 16:19:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-163000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-10 16:19:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-84927000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-10 16:19:23+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1954000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-10 16:19:23+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-83136000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-10 16:19:23+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-83136000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-10 16:19:23+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3598000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-10 16:19:23+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,75617000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-10 16:19:23+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,77779000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-10 16:19:23+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,149798000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-10 16:19:23+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,149798000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-10 16:19:23+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,49167000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32820000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32820000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,837000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,659000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4159000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1909000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-29074000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-29074000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-163000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-84927000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5354000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-79736000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-79736000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5159000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-999000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,75617000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,77781000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,147240000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,147240000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,38430000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,415000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11080000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11080000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,210000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,228000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,864000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1431000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11209000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11209000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-40000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-84927000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-84963000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-84963000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2803000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,501000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,29318000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,77710000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,104726000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,104726000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8554000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2016-05-11 16:11:28+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9071000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2016-05-11 16:11:28+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9071000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2016-05-11 16:11:28+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,209000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2016-05-11 16:11:28+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,132000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2016-05-11 16:11:28+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1937000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2016-05-11 16:11:28+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,507000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2016-05-11 16:11:28+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6286000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2016-05-11 16:11:28+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6286000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2016-05-11 16:11:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-123000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2016-05-11 16:11:28+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1950000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2016-05-11 16:11:28+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1827000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2016-05-11 16:11:28+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1827000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2016-05-11 16:11:28+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-795000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2016-05-11 16:11:28+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-501000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2016-05-11 16:11:28+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,46299000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2016-05-11 16:11:28+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,69000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2016-05-11 16:11:28+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,45072000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2016-05-11 16:11:28+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,45072000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2016-05-11 16:11:28+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,40613000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27328000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27328000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,835000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,528000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3516000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-316000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22765000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22765000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-161000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5350000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5189000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5189000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2356000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1500000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5000000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,46299000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,128000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,47571000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,47571000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,29995000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,415000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-57855000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-57855000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,900000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,531000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5231000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1668000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-52861000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-52861000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-600000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-28089000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,62216000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,33527000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,33527000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5202000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,9736000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,163000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4697000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4697000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14637000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,225000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12566000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12566000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,221000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,35000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1224000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-609000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11695000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11695000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-46000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1845000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10493000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8602000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8602000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2655000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,9736000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,68000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7149000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7149000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4056000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,225000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-14 16:17:24+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-45289000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-14 16:17:24+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-45289000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-14 16:17:24+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,679000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-14 16:17:24+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,496000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-14 16:17:24+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4007000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-14 16:17:24+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1059000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-14 16:17:24+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-41166000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-14 16:17:24+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-41166000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-14 16:17:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-554000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-14 16:17:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-26244000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-14 16:17:24+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,51723000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-14 16:17:24+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,24925000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-14 16:17:24+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,24925000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-14 16:17:24+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2547000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-14 16:17:24+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,95000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-14 16:17:24+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2452000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-14 16:17:24+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2452000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-14 16:17:24+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-18693000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-61782000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-61782000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,905000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,568000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6691000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2617000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-51001000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-51001000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-673000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-36281000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,65783000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,28829000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,28829000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3371000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-178000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3549000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3549000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3TTM,2015-10-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-25721000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3TTM,2015-10-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,925000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13819000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13819000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,222000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,99000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1257000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2446000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14687000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14687000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-64000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4320000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11072000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6688000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6688000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-861000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-860000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-860000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8859000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-14 17:10:45+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31470000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-14 17:10:45+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31470000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-14 17:10:45+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,457000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-14 17:10:45+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,397000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-14 17:10:45+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2750000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-14 17:10:45+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1387000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-14 17:10:45+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-26479000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-14 17:10:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-26479000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-14 17:10:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-490000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-14 17:10:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-21924000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-14 17:10:45+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,40651000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-14 17:10:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,18237000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-14 17:10:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,18237000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-14 17:10:45+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1686000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-14 17:10:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,94000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-14 17:10:45+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1592000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-14 17:10:45+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1592000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-14 17:10:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9834000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-59292000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-59292000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,907000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,826000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6484000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5294000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-45781000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-45781000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-991000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-46442000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,76812000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,29379000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,29379000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3325000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,31000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-179000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3473000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3473000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2TTM,2015-07-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-19875000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2TTM,2015-07-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,925000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15383000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15383000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,224000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,79000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1470000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-378000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13988000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13988000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-176000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-11930000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15951000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3845000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3845000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-848000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,83000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-765000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-765000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10908000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 16:16:35+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16087000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 16:16:35+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16087000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 16:16:35+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,233000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 16:16:35+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,318000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 16:16:35+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1280000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 16:16:35+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1765000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 16:16:35+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12491000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 16:16:35+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12491000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 16:16:35+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-314000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 16:16:35+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9994000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 16:16:35+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24700000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 16:16:35+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14392000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 16:16:35+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14392000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 16:16:35+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-838000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 16:16:35+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,11000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 16:16:35+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-827000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 16:16:35+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-827000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 16:16:35+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1074000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-54989000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-54989000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,893000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,975000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5878000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4241000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-43002000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-43002000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-855000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-119439000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,60865000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-59429000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-59429000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5280000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,501000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,29349000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,77448000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,102018000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,102018000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1TTM,2015-04-01,2016-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-413000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q1TTM,2015-04-01,2016-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,925000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-48207000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-48207000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,713000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,14000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7374000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2258000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-42364000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-42364000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1312000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-77672000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,51347000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-27637000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-27637000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,9866000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,42838000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,52704000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,52704000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-17297000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,1000000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11474000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11474000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,161000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-99000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3311000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2205000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10306000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10306000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-160000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-12370000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9000000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3530000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3530000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4936000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,226000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5162000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5162000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8674000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1000000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-14 16:07:17+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36733000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-14 16:07:17+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36733000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-14 16:07:17+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,552000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-14 16:07:17+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,113000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-14 16:07:17+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4063000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-14 16:07:17+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-53000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-14 16:07:17+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-32058000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-14 16:07:17+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-32058000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-14 16:07:17+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1152000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-14 16:07:17+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-65302000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-14 16:07:17+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,42347000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-14 16:07:17+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-24107000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-14 16:07:17+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-24107000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-14 16:07:17+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4930000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-14 16:07:17+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,42612000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-14 16:07:17+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,47542000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-14 16:07:17+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,47542000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-14 16:07:17+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8623000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-49299000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-49299000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,773000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,148000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5287000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-662000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-43753000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-43753000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1198000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-67147000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,52840000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15505000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15505000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2655000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,14666000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,42680000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,54691000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,54691000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3TTM,2016-10-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4567000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3TTM,2016-10-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,225000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11190000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11190000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,152000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1357000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,787000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8894000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8894000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-441000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-53813000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14497000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-39757000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-39757000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,42501000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,42501000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,42501000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6150000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-14 16:17:11+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25543000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-14 16:17:11+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25543000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-14 16:17:11+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,400000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-14 16:17:11+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,113000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-14 16:17:11+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2706000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-14 16:17:11+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-840000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-14 16:17:11+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23164000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-14 16:17:11+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23164000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-14 16:17:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-711000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-14 16:17:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-11489000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-14 16:17:11+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27850000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-14 16:17:11+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,15650000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-14 16:17:11+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,15650000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-14 16:17:11+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4930000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-14 16:17:11+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,111000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-14 16:17:11+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5041000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-14 16:17:11+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5041000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-14 16:17:11+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2473000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-51928000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-51928000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,843000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,247000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5187000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3895000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-49546000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-49546000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-821000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-17654000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,49415000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,30940000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,30940000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3516000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,14666000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,180000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,11330000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,11330000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2TTM,2016-07-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7276000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2TTM,2016-07-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,225000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12138000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12138000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,174000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,39000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1392000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1257000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9276000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9276000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-449000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11700000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,11251000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,11251000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4930000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,110000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5040000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5040000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7015000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13405000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13405000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,226000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,74000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1314000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2097000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13888000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13888000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-262000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-11489000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16150000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4399000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4399000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9488000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-55173000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-55173000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,893000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,287000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5265000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5530000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-54258000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-54258000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-548000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-29584000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,53666000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,23534000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,23534000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4364000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,9736000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,153000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5525000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5525000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1TTM,2016-04-01,2017-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-25199000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1TTM,2016-04-01,2017-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,225000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34515000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34515000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,746000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-261000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4415000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1448000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-31063000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-31063000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-594000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-40299000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,78065000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,37172000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,37172000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4667000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,429000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4238000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4238000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1871000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,1700000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-14 16:16:55+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28193000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-14 16:16:55+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28193000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-14 16:16:55+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,567000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-14 16:16:55+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,213000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-14 16:16:55+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3572000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-14 16:16:55+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2321000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-14 16:16:55+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-26162000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-14 16:16:55+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-26224000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-14 16:16:55+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-585000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-14 16:16:55+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-23375000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-14 16:16:55+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,63265000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-14 16:16:55+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,39305000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-14 16:16:55+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,39305000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-14 16:16:55+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2667000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-14 16:16:55+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,42000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-14 16:16:55+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2625000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-14 16:16:55+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2625000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-14 16:16:55+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,10456000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39667000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39667000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,728000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,114000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6883000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4526000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-36468000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-36530000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-745000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-35745000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,72265000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,35775000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,35775000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2667000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4936000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,268000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2537000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2537000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1782000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1000000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-14 16:54:59+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21079000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-14 16:54:59+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21079000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-14 16:54:59+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,376000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-14 16:54:59+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-119000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-14 16:54:59+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2640000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-14 16:54:59+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1582000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-14 16:54:59+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19764000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-14 16:54:59+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19764000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-14 16:54:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-549000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-14 16:54:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-23375000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-14 16:54:59+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,42500000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-14 16:54:59+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,18576000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-14 16:54:59+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,18576000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-14 16:54:59+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-667000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-14 16:54:59+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,36000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-14 16:54:59+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-631000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-14 16:54:59+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-631000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-14 16:54:59+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1819000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-43743000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-43743000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,689000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-218000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7308000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3000000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-38964000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-38964000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1150000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-89558000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,65997000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-24711000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-24711000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-667000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4936000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,42763000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,47032000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,47032000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16643000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1000000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10412000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10412000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,192000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-55000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1631000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-543000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9187000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9187000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-51000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-15387000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22600000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7162000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7162000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-667000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,28000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-639000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-639000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2664000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10667000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10667000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,184000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-64000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1009000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1039000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10577000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10577000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-498000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7988000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19900000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,11414000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,11414000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,845000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-45469000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-45469000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,671000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-124000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7069000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1200000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-39053000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-39053000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1548000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-74171000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,55097000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-20622000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-20622000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,9866000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,42845000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,52711000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,52711000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6964000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1000000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23763000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23763000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,635000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1015000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2518000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-462000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20057000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20013000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-79000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-40647000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,51000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,45600000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4925000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4925000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-8000000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9336000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1336000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1336000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13752000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,1122000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23952000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23952000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,657000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-183000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2729000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,751000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19998000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19936000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-47000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-51592000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,51000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,55600000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4012000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4012000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-8000000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9718000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1718000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1718000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14206000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1700000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5645000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5645000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,154000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,142000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,422000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,674000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4253000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4253000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-28000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4588000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,25000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11800000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7209000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7209000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2000000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1878000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-122000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-122000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2834000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-14 16:16:55+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17630000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-14 16:16:55+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17630000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-14 16:16:55+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,478000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-14 16:16:55+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,291000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-14 16:16:55+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1886000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-14 16:16:55+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-122000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-14 16:16:55+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15097000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-14 16:16:55+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15097000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-14 16:16:55+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-38000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-14 16:16:55+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-34668000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-14 16:16:55+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,51000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-14 16:16:55+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,40800000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-14 16:16:55+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6145000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-14 16:16:55+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6145000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-14 16:16:55+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-6000000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-14 16:16:55+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9331000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-14 16:16:55+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3331000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-14 16:16:55+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3331000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-14 16:16:55+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5621000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25421000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25421000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,694000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,7000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3239000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-662000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22143000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22143000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-55000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-47004000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,26000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,64565000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,17532000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,17532000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-8000000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7846000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-154000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-154000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4765000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1700000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5848000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5848000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,157000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,86000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1322000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-538000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4821000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4821000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-16085000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,26000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,18350000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2291000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2291000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2000000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6072000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4072000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4072000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1542000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-14 16:54:59+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11985000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-14 16:54:59+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11985000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-14 16:54:59+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,324000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-14 16:54:59+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,149000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-14 16:54:59+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1464000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-14 16:54:59+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-796000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-14 16:54:59+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10844000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-14 16:54:59+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10844000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-14 16:54:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-10000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-14 16:54:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-30080000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-14 16:54:59+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,26000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-14 16:54:59+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,29000000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-14 16:54:59+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1064000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-14 16:54:59+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1064000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-14 16:54:59+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4000000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-14 16:54:59+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7453000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-14 16:54:59+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3453000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-14 16:54:59+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3453000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-14 16:54:59+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8455000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6137000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6137000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,167000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,63000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,142000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-258000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6023000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6023000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-10000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-13995000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10650000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3355000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3355000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2000000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1381000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-619000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-619000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9997000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29985000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29985000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,729000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-134000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3548000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-667000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-26509000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-26509000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-106000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-46306000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,68815000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,22403000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,22403000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-6667000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1802000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4865000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4865000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8971000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1700000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15874000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15874000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,625000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1129000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2934000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-790000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11976000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11932000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-235000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-29733000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,54000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,49600000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,19686000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,19686000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-8000000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,26734000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,18734000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,18734000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,26488000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1122000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1752000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1752000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,157000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,177000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,558000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-586000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2058000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2058000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-166000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3081000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,3000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14650000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,11406000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,11406000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2000000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,18779000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,16779000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,16779000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,30243000.0
